Shilepi 50mg Injection
Marketer
Shilpa Medicare Ltd
Salt Composition
Epirubicin (50mg)
Overview Shilepi 50mg Injection
Shilepi 50mg injection treats various blood, breast, stomach, lung, ovarian, and soft tissue cancers. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it's used alone or in combination chemotherapy. Dosage and frequency are determined by your doctor based on your condition and may vary. Strictly follow prescribed instructions; improper use or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months; discontinue only under medical guidance. Contraceptive effectiveness is reduced; reliable contraception is recommended for both sexes during treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, fever, and rash. Reduced blood cell counts increase infection risk, potentially life-threatening. Regular blood tests monitor blood cell counts, kidney, liver, and heart function. Before use, disclose liver or heart conditions, and all other medications, as interactions may impact efficacy. Report pregnancy or breastfeeding to your physician.
Uses of Shilepi 50mg Injection
Malignancy
Major Benefits of Shilepi 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Shilepi 50mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Shilepi 50mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Shilepi 50mg Injection works:
The anti-neoplastic agent, Shilepi 50mg Injection, targets breast cancer cells by inhibiting topoisomerase II, a crucial enzyme in DNA replication. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage, ultimately hindering tumor growth and inducing cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Shilepi 50mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Shilepi 50mg Injection during pregnancy carries established risks to the fetus. Its use is contraindicated except in exceptional, life-threatening circumstances where the potential benefits outweigh the known dangers, as determined by a physician. Seek medical advice before use.
Breast feedingUNSAFE
Administering Shilepi 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Shilepi 50mg Injection may induce adverse reactions that could compromise driving capabilities. Nausea and vomiting, potential side effects of Shilepi 50mg Injection, may temporarily affect one's ability to operate a vehicle.
KidneySAFE IF PRESCRIBED
Shilepi 50mg Injection appears to pose minimal risk for individuals with kidney impairment. Current evidence indicates dose modification might not be necessary for this patient group. However, physician consultation is advised. A reduced dosage should be explored if serum creatinine levels exceed 5 mg/dL.
LiverCAUTION
Patients with liver impairment should receive Shilepi 50mg Injection cautiously, potentially requiring dose modification. Physician consultation is advised. Shilepi 50mg Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Shilepi 50mg Injection :
NA
Facts to Know About Shilepi 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Anthracycline Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Cytotoxic alkaloids |
3,018 People bought this recently